MON 810
MON 810 is a genetically modified maize (corn) variety produced by Monsanto. It is engineered to express a Bacillus thuringiensis gene, which confers resistance to the European Corn Borer (Ostrinia nubilalis), a significant pest of maize crops. The modification allows the maize to produce a Bt toxin that is toxic to certain insect pests but is claimed to be safe for human consumption and the environment. MON 810 was one of the first genetically modified crops to be commercialized.
Development and Approval[edit | edit source]
MON 810 was developed through the insertion of a gene from the bacterium Bacillus thuringiensis into the maize genome. This gene encodes for the production of the Bt toxin, which disrupts the gut lining of the corn borer larvae, ultimately causing death. The development of MON 810 aimed to provide farmers with an alternative to chemical pesticides, reducing the environmental impact and potentially lowering the cost of maize production.
The variety has been approved for cultivation and/or food and feed use in several countries around the world. However, its approval and use have been subject to controversy and regulatory scrutiny. In the European Union, for example, some member states have invoked safeguard clauses or implemented bans on the cultivation of MON 810, citing environmental or health concerns.
Controversies and Regulations[edit | edit source]
The cultivation and use of MON 810, as with other genetically modified organisms (GMOs), have been a subject of debate. Proponents argue that it offers an efficient solution to pest management, can contribute to higher yields, and reduce the need for chemical pesticides. Critics, however, raise concerns about potential long-term impacts on human health, the environment, and biodiversity. Issues such as gene flow to non-GMO crops, the development of resistance in target pest populations, and effects on non-target organisms are frequently cited.
In response to these concerns, regulatory bodies in various jurisdictions have established stringent assessment and approval processes for GMOs like MON 810. These processes evaluate the safety of the GMO for human and animal consumption, as well as its environmental impact.
Labeling and Traceability[edit | edit source]
In regions where MON 810 is approved for use, there are often regulations in place regarding its labeling and traceability. This is particularly true in the European Union, where GMO foods and feeds must be labeled, allowing consumers to make informed choices. Traceability requirements ensure that GMO products can be tracked through the supply chain, facilitating the withdrawal of products if safety concerns arise.
Current Status[edit | edit source]
The cultivation and sale of MON 810 continue to be a contentious issue, with its status varying significantly by country. While it remains a valuable tool for some farmers, the ongoing debates reflect broader societal concerns about the role and regulation of GMOs in agriculture.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD